Key details
Phase
Early testing / Safety & dosing
Sponsor
Chinese PLA General Hospital
Enrollment target
~90 participants
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated December 2024